Cargando…
Management of non-alcoholic fatty liver disease incidentally detected during other medical assessments
Elevated liver enzyme levels are a frequent incidental finding in primary care, and non-alcoholic fatty liver disease is the main cause of incidental elevation of liver enzymes worldwide. The features of the disease vary from simple steatosis, characterized by a benign prognosis, to non-alcoholic st...
Autores principales: | Lee, Yeong Yeh, Tee, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187607/ https://www.ncbi.nlm.nih.gov/pubmed/37205125 http://dx.doi.org/10.7573/dic.2023-1-3 |
Ejemplares similares
-
Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
por: Lee, Yeong Yeh, et al.
Publicado: (2023) -
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020) -
Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
por: Lee, Yeong Yeh, et al.
Publicado: (2023) -
Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020) -
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)